CURRICULUM VITAE

BURHAN FERHANOGLU, MD.

Professor of Medicine

University of Koc

Department of Internal Medicine

Division of Hematology

EDUCATION

1972 Vefa High School, Istanbul

1978 University of Istanbul Medical School

1978-1982 Istanbul University, Medical School, Department of Internal Medicine,

Resident

1982-1984 Military work at Bursa Military Hospital, Department of Internal Medicine

1984-1986 Corum State Hospital, Department of Internal Medicine

1986-1988 Cerrahpasa Medical School, Department of Internal Medicine, Hematology

Fellow

1988-1990 Associate professor of Hematology, Cerrahpasa Medical School

1990-1991 University of Texas, Health Science Center, Department of Hematology,

Research Fellow, Basic Science Research

1991-1992 Cerrahpasa Medical School, Associate Professor

1992-1993 Fred Hutchinson Cancer Center, Bone Marrow Transplantation Experience

1993 -1994 Associate professor of Cerrahpasa Medical School

1994-2012 Professor of Hematology, Cerrahpasa Medical school

1998- …. V.K.V. American Hospital, Chair of Department of Hematology

2012- … Koc University School of Medicine, Department of Hematology

1

MEMBERSHIP of SCIENTIFIC SOCIETIES

1. Turkish Society of Hematology

2. International Society of Hematology

3. American Society of Hematology

4. European Bone Marrow Transplantation Society

5. European Hematology Association

6. Helenic Society of Hematology

REFEREEING in

1. Annals of Oncology

2. Journal of Istanbul Faculty of Medicine

3. Journal of Osmangazi Faculty of Medicine

4. Journal of Cukurova Faculty of Medicine

5. Turkish Journal of Hematology

6. Journal of Clinical Evolution

PUBLICATIONS

Peer-reviewed Papers Published in International Journals

1. Ferhanoglu B, Ozturk E, Ozbalak M. Venetoclax-Rituximab in Chronic

Lymphocytic Leukemia. The New England journal of medicine. 2018; 378(22): 2141-2.

2. Ozturk E, Akay MO, Ferhanoglu B. Recognizing Pinch Purpura as the First

Manifestation of Light-chain Amyloidosis. Turk J Haematol. 2018; 35(3): 208-9.

3. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C,

Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell

P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist

W, Deraedt W, Nguyen H, Qi M, San-Miguel J, Investigators AT. Daratumumab plus

Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. The New England

journal of medicine. 2018; 378(6): 518-28.

4. Madran B, Keske S, Tokca G, Donmez E, Ferhanoglu B, Cetiner M, Mandel NM,

Ergonul O. Implementation of an antimicrobial stewardship program for patients with

febrile neutropenia. American journal of infection control. 2018; 46(4): 420-4.

2

5. Bekoz H, Karadurmus N, Paydas S, Turker A, Toptas T, Firatli Tuglular T, Sonmez

M, Gulbas Z, Tekgunduz E, Kaya AH, Ozbalak M, Tastemir N, Kaynar L, Yildirim R,

Karadogan I, Arat M, Pepedil Tanrikulu F, Ozkocaman V, Abali H, Turgut M, Kurt Yuksel

M, Ozcan M, Dogu MH, Kabukcu Hacioglu S, Barista I, Demirkaya M, Koseoglu FD, Toprak

SK, Yilmaz M, Demirkurek HC, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or

refractory Hodgkin lymphoma: real-life experience. Ann Oncol. 2017; 28(10): 2496-502.

6. Ozturk E, Ozyigit LP, Ozturk AB, Akay MO, Cetiner M, Ferhanoglu B. Rituximab

desensitization in three patients with severe rituximab allergy. Current problems in

cancer. 2017; 41(5): 349-54.

7. Ozbalak M, Torun ES, Ozdemirli M, Ucar AR, Akpinar TS, Tascioglu C, Ferhanoglu

B. Inflammatory myofibroblastic tumor mimicking a relapse in a patient with Hodgkin's

lymphoma: report of an unusual case and review of the literature. Clinical case reports.

2017; 5(6): 945-9.

8. Falay O, Ozturk E, Bolukbasi Y, Gumus T, Ornek S, Ozbalak M, Cetiner M, Demirkol

O, Ferhanoglu B. Use of fluorodeoxyglucose positron emission tomography for diagnosis

of bleomycin-induced pneumonitis in Hodgkin lymphoma. Leuk Lymphoma. 2017; 58(5):

1114-22.

9. Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Cetiner M, Ferhanoglu B, Sargin

D. Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of

Hematology and Blood Transfusion. 2016; 32(Suppl 1): 178-80.

10. Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap

O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar

L. Azacitidine versus decitabine in patients with refractory anemia with excess blast-

Results of multicenter study. Leuk Res. 2016; 45: 82-9.

11. Tekgunduz E, Sencan I, Kapuagasi A, Unal D, Ozturk M, Gumus E, Goker H, Tavil

EB, Ertem M, Cetin M, Arat M, Soysal T, Karakasli O, Sur HY, Yesilipek A, Ferhanoglu B,

Uckan D, Ilhan O, Altuntas F. Hematopoietic cell transplantation activity of Turkey in

2014: Ongoing increase in HCT rates. Transfus Apher Sci. 2016.

12. Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A,

Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U,

Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. Imatinib reduces bone marrow fibrosis and

overwhelms the adverse prognostic impact of reticulin formation in patients with

chronic myeloid leukaemia. J Clin Pathol. 2016.

3

13. Yemisen M, Balkan, II, Salihoglu A, Eskazan AE, Mete B, Ar MC, Ongoren S, Baslar

Z, Ozaras R, Saltoglu N, Mert A, Ferhanoglu B, Ozturk R, Tabak F, Soysal T. The

Changing Epidemiology of Blood Stream Infections and Resistance in Haematopoietic

Stem Cell Transplantation Recipients. Turk J Haematol. 2015.

14. Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N,

Akyol G, Kaynar L, Yegin Z, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E,

Goker H, Baslar Z, Ferhanoglu B. Brentuximab vedotin for relapsed or refractory

Hodgkin lymphoma: experience in Turkey. Ann Hematol. 2015; 94(3): 415-20.

15. Ozturk E, Ozbalak M, Berk S, Erdogan I, Avsar E, Dolgun A, Cetiner M, Mandel NM,

Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Ongoren S, Baslar Z, Aydin Y,

Soysal T, Ferhanoglu B. Comparison of International Prognostic Index and NCCN-IPI

in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective

analysis. Leuk Lymphoma. 2015: 1-4.

16. Offner F, Samoilova O, Osmanov E, Eom HS, Topp MS, Raposo J, Pavlov V, Ricci

D, Chaturvedi S, Zhu E, van de Velde H, Enny C, Rizo A, Ferhanoglu B. Frontline

rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP)

or vincristine (R-CHOP) for non-GCB DLBCL. Blood. 2015; 126(16): 1893-901.

17. Islak Mutcali S, Saltoglu N, Balkan, II, Ozaras R, Yemisen M, Mete B, Tabak F, Mert

A, Ozturk R, Ongoren S, Baslar Z, Aydin Y, Ferhanoglu B, Soysal T. Early Changes of

Mannose Binding Lectin, H-ficolin and Procalcitonin in Patients With Febrile

Neutropenia: A Prospective, Observational Study. Turk J Haematol. 2015.

18. Demirel A, Tabak F, Ar MC, Mete B, Ongoren S, Yemisen M, Ozaras R, Eskazan AE,

Baslar Z, Mert A, Soysal T, Ferhanoglu B, Aydin Y, Ozturk R. Secondary Infections in

Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile

Neutropenic Episode. Turk J Haematol. 2015.

19. Aydin SO, Eskazan AE, Berk S, Erdogan I, Yalniz FF, Elverdi T, Salihoglu A, Ar

MC, Baslar Z, Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y. Retrospective Evaluation of

83 Patients with Hairy Cell Leukemia Treated with 3 Different Treatment Modalities in

the Last Two Decades: A Single Center Experience. Haematologica. 2015; 100: 424-5.

20. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic

contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014; 19:

53-8.

21. Soysal T, Salihoglu A, Esatoglu SN, Gulturk E, Eskazan AE, Hatemi G, Hatemi I,

Aydin SO, Erzin YZ, Baslar Z, Tuzuner N, Ferhanoglu B, Celik AF. Bone marrow

4

transplantation for Behcet's disease: a case report and systematic review of the

literature. Rheumatology. 2014; 53(6): 1136-41.

22. Ferhanoglu B, Salihoglu A, Elverdi T, Karadogan I, Ozdemir E, Erdem G,

Karadurmus N, Akyol G, Kaynar L, Yegin A, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan

M, Birtas E, Goker H, Baslar Z, Paydas S. Brentuximab Vedotin for Relapsed or

Refractory Hodgkin Lymphoma: Experience in Turkey. Haematologica. 2014; 99: 675-6.

23. Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren

Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Chronic

myeloid leukemia patients who develop grade I/II pleural effusion under second-line

dasatinib have better responses and outcomes than patients without pleural effusion.

Leuk Res. 2014; 38(7): 781-7.

24. Cetin G, Eskazan AE, Ar MC, Aydin SO, Ferhanoglu B, Soysal T, Baslar Z, Aydin

Y. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma

Receiving Various Therapy Options. Turk J Haematol. 2014; 31(4): 374-80.

25. Berk S, Ozgur N, Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Baslar Z,

Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y, Aydin SO. Primary Gastointestinal Non-

Hodgkin's Lymphoma: Retrospective Evaluation of 50 Patients. Haematologica. 2014;

99: 694-.

26. Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens

L, Pocock CF, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J,

Ferhanoglu B, Bradstock K, Linch DC. Rituximab versus a watch-and-wait approach in

patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-

label randomised phase 3 trial. Lancet Oncol. 2014; 15(4): 424-35.

27. Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B.

Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the

relapse setting: two case reports and a review of the literature. Transfusion. 2013; 53(7):

1586-93.

28. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic

Contribution of F-18 FDG-PET/CT on the Management of FUO. Eur J Nucl Med Mol I.

2013; 40: S138-S.

29. Salihoglu A, Ozbalak M, Keskin D, Tecimer T, Soysal T, Ferhanoglu B. An unusual

presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-

intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--

case report. Transplant Proc. 2013; 45(7): 2845-8.

5

30. Salihoglu A, Hatemi I, Senel TE, Aki H, Ferhanoglu B. Massive gastrointestinal

bleeding during the course of chronic myelomonocytic leukemia. J Gastrointestin Liver

Dis. 2013; 22(1): 7.

31. Sahin F, Saydam G, Comert M, Uz B, Yavuz AS, Turan E, Yonal I, Atay H, Keltikli

E, Turgut M, Pehlivan M, Akay MO, Gurkan E, Paydas S, Kahraman S, Demirkan F,

Kirkizlar O, Akpinar S, Pamuk GE, Demir M, Ozbas HM, Sonmez M, Gulturk M, Salihoglu

A, Eskazan AE, Ar C, Haydaroglu Sahin H, Ongoren S, Baslar Z, Aydin Y, Yenere MN,

Tuzuner N, Ferhanoglu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid

Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turk J Haematol.

2013; 30(4): 351-8.

32. Ozbalak M, Tokatli I, Ozdemirli M, Tecimer T, Ar MC, Ornek S, Koroglu A, Laleli

Y, Ferhanoglu B. Is valganciclovir really effective in primary effusion lymphoma: case

report of an HIV(-) EBV(-) HHV8(+) patient. Eur J Haematol. 2013; 91(5): 467-9.

33. Ozbalak M, Ar MC, Tuzuner N, Salihoglu A, Eskazan AE, Ongoren Aydin S, Baslar

Z, Soysal T, Aydin Y, Barak Dolgun A, Ergonul O, Ferhanoglu B. Detailed analysis of

diffuse large B cell lymphoma patients: a single-center, retrospective study. ISRN

Hematol. 2013; 2013: 908191.

34. Erbilgin Y, Eskazan AE, Ng OH, Salihoglu A, Elverdi T, Firtina S, Tatonyan SC,

Aydin SO, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu AB, Aydin Y, Ozbek U, Soysal T.

Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision

Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor

Resistance. Blood. 2013; 122(21).

35. Aki H, Uzunaslan D, Saygin C, Demir H, Salihoglu A, Ferhanoglu B, Tuzuner N.

Clinicopathologic features of primary thyroid lymphomas: A single center experience.

Virchows Arch. 2013; 463(2): 151-.

36. Selcukbiricik F, Tural D, Elicin O, Berk S, Ozguroglu M, Bese N, Ferhanoglu B.

Primary gastric lymphoma: conservative treatment modality is not inferior to surgery

for early-stage disease. ISRN Oncol. 2012; 2012: 951816.

37. Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in

Turkish, Title: Diffuse Large B Cell Lymphoma). HematoLog-Special Issue on

Lymphoma. 2013; 3(2): 355-81.

38. Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article

published in Turkish, Title: Primary Central Nervous System Lymphomas).

HematoLog-Special Issue on Lymphoma. 2013; 3(2): 382-94.

6

39. Ozturk M, Ozaydin S, Oyan B, Ozbalak M, Arpaci F, Paydas S, Ataergin S,

Ferhanoglu B, Kocak N, Gurkan E, Ozet A, Barista I. The comparison of up-front

autologous peripheral stem cell transplantation in first remission and long-lasting

intensive chemotherapy protocols in highly aggressive non-Hodgkin's lymphomas:

Results of a retrospective analysis. J Clin Oncol. 2012; 30(15).

40. Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N,

Ferhanoglu B. Azacitidine has limited activity in 'real life' patients with MDS and AML:

a single centre experience. Hematol Oncol. 2012; 30(2): 76-81.

41. Ari MC, Buyuktas D, Eskazan AE, Ongoren Aydin S, Tanrikulu E, Baslar Z, Buyru

AN, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. The Association Between JAK2V617F

Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-

Negative Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2012; 29(3): 242-7.

42. Offner F, Ferhanoglu B, Reeves JA, Eom HS, Doner K, Raposo J, Flinn IW, Suh C,

Chowhan NM, Prasad S, Kussick SJ, Mulligan G, Rizo A, Leonard JP. Phase 2 Studies of

Immunochemotherapy +/- Bortezomib (Vc) in Newly Diagnosed Non-Germinal Center

B-Cell-Like (Gcb) Dlbcl: Rapid Prospective Identification of Non-Gcb Patients (Pts).

Ann Oncol. 2011; 22: 225-.

43. Leonard J, Reeves J, Ferhanoglu B, Doner KT, Eom H, Flinn IW, Raposo J,

Chowhan NM, Suh C, Noga S, Tumyan G, Aung S, Hajdenberg J, Ulrich BK, Pendergrass

KB, Mulligan G, Rizo A, Kussick S, Offner F. PYRAMID and LYM2034: Targeted

randomized phase II studies of bortezomib with or without immunochemotherapy in

newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma

(DLBCL), including rapid prospective non-GCB subtype identification. J Clin Oncol.

2011; 29(15).

44. Eskazan AE, Tatonyan SC, Salihoglu A, Gulturk E, Ar MC, Aydin SO, Baslar Z,

Ferhanoglu AB, Tuzuner N, Aydin Y, Ozbek U, Soysal T. Multidrug Resistance Gene

(MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic

Myeloid Leukemia. Blood. 2011; 118(21): 736-.

45. Eskazan AE, Soysal T, Ongoren S, Gulturk E, Ferhanoglu B, Aydin Y. Pleural and

pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib

therapy. Haematologica. 2011; 96(3): e15; author reply e6-7.

46. Eskazan AE, Soysal T, Erbilgin Y, Ozbek U, Ferhanoglu B. Chronic myeloid

leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to

dasatinib: is that true for all the patients? Leuk Res. 2011; 35(9): e145-6.

7

47. Eskazan AE, Ongoren S, Ar MC, Soysal T, Ferhanoglu B, Aki H, Aydin Y. Essential

thrombocythemia and multiple myeloma: two rare diseases in one patient. Clin

Lymphoma Myeloma Leuk. 2011; 11(5): 442-5.

48. Eskazan AE, Akmurad H, Ongoren S, Ozer O, Ferhanoglu B. Primary

gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease.

Case Rep Gastroenterol. 2011; 5(2): 262-6.

49. Arslan F, Tabak F, Avsar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R,

Ferhanoglu B. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic

stem cell transplant recipient. J Neurovirol. 2010; 16(2): 174-8.

50. Ardeshna KM, Qian WD, Smith P, Warden J, Stevens L, Pocock CFE, Miall F,

Cunningham D, Davies J, Walewski J, Ferhanoglu AB, Bradstock K, Linch DC. An

Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In

Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicullar Lymphoma

(Grades 1, 2 and 3a). A Preliminary Analysis. Blood. 2010; 116(21): 5-.

51. Ure U, Ar MC, Baslar Z, Soysal T, Ongoren S, Gulseven M, Aydin Y, Ulku B,

Tuzuner N, Ferhanoglu B. The Effect of ZAP-70 Expression on Disease Progression in

Early-Stage (Binet A) B-CLL Patients. Trak Univ Tip Fak De. 2009; 26(4): 317-21.

52. Tarkan-Arguden Y, Ar MC, Yilmaz S, Ongoren S, Kuru D, Ure U, Cirakoglu A,

Eskazan AE, Guven GS, Cetin G, Purisa S, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S,

Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Cytogenetic Clonal Evolution in Patients

with Chronic Myeloid Leukemia. Biotechnol Biotec Eq. 2009; 23(4): 1515-20.

53. Saydam G, Haznedaroglu IC, Temiz Y, Soysal T, Sucak G, Tombuloglu M, Ozdogu

H, Yavuz S, Altintas A, Ozet G, Gulbas Z, Ferhanoglu B, Ilhan O. Retrospective

Evaluation of Patients Treated with Dasatinib for Philadelphia Positive Leukemias:

Turkish Experience of 16 Months. Uhod-Uluslar Hematol. 2009; 19(4): 195-204.

54. Ozer O, Eskazan AE, Ar MC, Bekoz H, Tabak F, Ongen G, Ferhanoglu B.

Sarcoidosis mimicking lymphoma on positron emission tomography-computed

tomography in two patients treated for lymphoma: two case reports. J Med Case Rep.

2009; 3: 7306.

55. Ongoren S, Tarkan-Arguden Y, Ar MC, Yilmaz S, Ure U, Kuru D, Eskazan AE,

Guven GS, Cetin G, Cirakoglu A, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S,

Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Clonal Chromosomal Abnormalities in

Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic

Myeloid Leukemia: Results of a Single Center. Turk Klin Tip Bilim. 2009; 29(2): 321-30.

8

56. Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B.

Severe bone marrow failure due to valganciclovir overdose after renal transplantation

from cadaveric donors: four consecutive cases. Transplant Proc. 2009; 41(5): 1648-53.

57. Igdem S, Okkan S, Unalan B, Igdem A, Ferhanoglu B. Cervical cancer coexisting

with small lymphocytic lymphoma detected during positron emission

tomography/computed tomography simulation: a case report. Eur J Gynaecol Oncol.

2008; 29(4): 405-7.

58. Erdogan EB, Guner SI, Sonmezoglu K, Ferhanoglu B, Halac M, Uslu I. Can post-

treatment PET/CT scanning after first-line chemotherapy predict the prognosis in

patients with Hodgkin disease and high-grade nonHodgkin lymphoma? Eur J Nucl Med

Mol I. 2008; 35: S221-S.

59. Ure UB, Ar MC, Salihoglu A, Guner SI, Baran A, Oguz O, Ferhanoglu B.

Alemtuzumab in Sezary syndrome: efficient but not innocent. Eur J Dermatol. 2007;

17(6): 525-9.

60. Üre Ü, Özer Ö, Beköz H, Tüzüner N, Ferhanoglu B. İmages 96: Hodgkin

Lymphoma Presenting as a Palpable Scalp Mass. Bloodmed. 2007.

61. Soer M, Ozbalak M, Senocak M, Soysal T, Ferhanoglu B, Molinas N, Tuzuner N.

Prognostic significance of micro vessel density in diffuse large B cell lymphomas .

Virchows Arch. 2007; 451(2): 357-8.

62. Sili U, Yilmaz M, Ferhanoglu B, Mert A. Candida krusei arthritis in a patient with

hematologic malignancy: successful treatment with voriconazole. Clin Infect Dis. 2007;

45(7): 897-8.

63. Ozer O, Eskazan E, Bekoz H, Peker K, Yuksel S, Altiok E, Ferhanoglu B. A case of

V617F(+) myelodysplastic/myeloproliferative disorder. Virchows Arch. 2007; 451(2):

434-.

64. Hatirnaz O, Ure U, Ar C, Akyerli C, Soysal T, Ferhanoglu B, Ozcelik T, Ozbek U.

The SOCS-1 gene methylation in chronic myeloid leukemia patients. Am J Hematol.

2007; 82(8): 729-30.

65. Hatirnaz O, Ekmekci CG, Ar C, Ure U, Soysal T, Ferhanoglu B, Ozbek U. Detection

of SOCS-1 (suppressor of cytokine signaling-1) methylation in CML (chronic myeloid

leukemia) patients. Febs J. 2006; 273: 322-.

66. Pamuk ON, Pamuk GE, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y,

Ulku B, Aktuglu G, Akman N. Chronic lymphocytic leukemia in Turkey: experience of a

single center in Istanbul. South Med J. 2004; 97(3): 240-5.

9

67. Aki H, Tuzuner N, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Sahinler I, Aydin

Y, Ulku B, Aktuglu G. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases

and comparison with 43 cases of diffuse large B-cell lymphoma. Leuk Res. 2004; 28(3):

229-36.

68. Gurses N, Kalayoglu-Besisik S, Sargin D, Ferhanoglu B, Anak S, Soysal T, Baslar Z,

Ongoren S, Bilgen H, Gedykoglu G, Aydin M, Abacy N, Gul A, Ozbek U. Interleukin-6

gene polymorphisms associate with acute graft-versus-host disease in HLA-matched

allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2003; 31: S129-

S.

69. Ferhanoglu B, Ongoren S, Ar CM, Uzel B, Forta H, Necioglu D. Intrathecal

methotrexate-induced acute cerebellar syndrome. Ann Hematol. 2003; 82(4): 241-3.

70. Akan H, Uzun O, Akova M, Senol E, Ozkalemkas F, Ferhanoglu B, Dincer S, Korten

V. FUNGOBASE: An epidemiological study to determine the trends in antifungal

treatment in Turkey. Trends in Medical Mycology. 2003: 43-7.

71. Tiryakioglu O, Kadioglu P, Ongoren S, Acbay O, Ferhanoglu B, Gundoglu S,

Korugan U. An unusual cause of hypercalcemia in polycythemia vera: parathyroid

adenoma. Acta Med Okayama. 2002; 56(3): 167-70.

72. Pamuk GE, Pamuk ON, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y,

Ulku B, Aktuglu G, Akman N. An overview of young CLL patients: a single-centre

experience from Turkey. Haematologia. 2002; 31(4): 303-11.

73. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y,

Ulku B, Aktuglu G, Akman N. Overview of 321 patients with idiopathic

thrombocytopenic purpura. Retrospective analysis of the clinical features and response

to therapy. Ann Hematol. 2002; 81(8): 436-40.

74. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N,

Anak S, Baslar Z, Soysal T, Ferhanoglu B, Gedikoglu G, Sargin D. The value of TNF-

alpha and IL-10 gene polymorphisms in the incidence and severity of graft-versus-host

disease. Bone Marrow Transpl. 2002; 29: S198-S.

75. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N,

Abaci N, Anak S, Baslar Z, Soysal T, Gul A, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G,

Gedikoglu G, Sargin D. Cytokine gene polymorphism in patients with graft-versus-host

disease after HLA-matched bone marrow transplantion. Blood. 2001; 98(11): 361b-b.

10

76. Ferhanoglu AB, Acicbe O, Ongoren S, Tabak F, Baslar Z, Ozturk R, Soysal T, Mert

A, Yilmaz M, Murtezaoglu A, Aydin Y, Ulku B, Aktuglu G, Aktuglu Y. Profile of

microorganisms isolated from febrile neutropenic patients. Blood. 2001; 98(11): 26b-b.

77. Erman M, Akova M, Akan H, Korten V, Ferhanoglu B, Koksal I, Cetinkaya Y, Uzun

O, Unal S. Comparison of cefepime and ceftazidime in combination with amikacin in the

empirical treatment of high-risk patients with febrile neutropenia: a prospective,

randomized, multicenter study. Scand J Infect Dis. 2001; 33(11): 827-31.

78. Soysal T, Pamuk ON, Pamuk GE, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y,

Ulku B, Aktuglu G, Akman N. An overview of young CLL patients. Blood. 2000; 96(11):

294b-b.

79. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y,

UIku B, Aktuglu G, Akman N. A single center experience with 321 ITP patients. Blood.

2000; 96(11): 68b-9b.

80. Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP,

Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid

HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula

A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff

P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit

T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S. A prospective randomized

study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and

high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1

Study. Leuk Lymphoma. 2000; 40(1-2): 95-103.

81. Demircioglu M, Ongoren S, Uzel B, Karadogan I, Aky H, Tuzuner N, Undar L,

Ferhanoglu B. Comparison of flow cytometry with other methods in diagnosis of PNH.

Blood. 2000; 96(11): 10b-b.

82. Budak T, Besisik S, Akan H, Baslar Z, Ratip S, Koc H, Ferhanoglu B, Bayik M,

Tangun Y. The prevalence of tuberculosis (TBC) in adult allogeneic stem cell transplant

recipients in Turkey. Bone Marrow Transpl. 1999; 23: S123-S.

83. Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aktuglu G, Ulkii B. Extramedullary

relapse after allogeneic stem cell transplantation. Bone Marrow Transpl. 1999; 23: S2-S.

84. Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female

alopecia? J Eur Acad Dermatol Venereol. 1999; 13(1): 65-7.

11

85. Ulutin ON, Ulutin ŞB, Çizmeci G, T U, Ferhanoglu B. Some Clinical,

Pharmacological Observations of the Effect of Defibrotide in Human. Acta

Pharmaceutica Turcica. 1998; (30): 57-62.

86. Soysal T, Baslar Z, Ferhanoglu B, Akman N. Donor leukocyte infusions for acute

myeloid leukemia relapsing after stem cell transplantation. Acta Haematol. 1998; 99(1):

49-51.

87. Baslar Z, Soysal T, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successfully

treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant

recipient. Bone Marrow Transpl. 1998; 22(4): 404-5.

88. Ozen S, Ferhanoglu B, Senocak M, Tuzuner N. Idiopathic myelofibrosis (agnogenic

myeloid metaplasia): clinicopathological analysis of 32 patients. Leuk Res. 1997; 21(2):

125-31.

89. Ozbek U, Vural B, Kalayoglu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D,

Gedikoglu G, Ferhanoglu B, Akoglu T, Tangun Y, Ozcelik T. Evaluation of chimerism

with DNA polymorphisms in bone marrow transplantation. Turk J Pediatr. 1997; 39(3):

303-11.

90. Ferhanoglu B, Erzin Y, Baslar Z, Tuzuner HA. Secondary amyloidosis in the

course of idiopathic myelofibrosis. Leuk Res. 1997; 21(9): 897-8.

91. Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B.

Successful outcome of aspergillus brain abscess in a patient who underwent bone

marrow transplantation for aplastic anemia. Haematologia. 1997; 28(4): 265-71.

92. Başlar Z, Tüfekçi IB, Soysal T, Ferhanoğlu B, Aydın Y, Aktuğlu G, Akman N , B Ü.

Neutropenic Enterocolitis In Acute Leukemia. Turkish Journal Of Haematology. 1997;

(14): 109-12.

93. Ulutin ON, Balkuv-Ulutin S, Bezer-Goker B, Cizmeci G, Ferhanoglu B, Ozsoy Y,

Ugur MS, Ulutin T, Yaman A, Yardimci T. Effect of defibrotide on platelet function.

Semin Thromb Hemost. 1996; 22 Suppl 1: 21-4.

94. Sayman HB, Sonmezoglu K, Altiok E, Devranoglu G, Ferhanoglu B. Unexpected

bone marrow uptake of thallium-201 in nonsecretory myeloma. J Nucl Med. 1995; 36(2):

250-1.

95. Soysal T, Ferhanoglu B, Bilir M, Akman N. Oculomotor nerve palsy associated

with vincristine treatment. Acta Haematol. 1993; 90(4): 209-10.

12

96. Ertugrul H, Aydemir A, Ferhanoglu B, Oğuz O, Akçakaya N, Tozakı S, Avanoglu Y,

Y G. Hyper IgE Syndrome Amiloidosis and Developmental Defect. Turkish Journal of

Medical and Biological Research. 1992; (3): 305-9.

97. Wu KK, Sanduja R, Tsai AL, Ferhanoglu B, Loose-Mitchell DS. Aspirin inhibits

interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells.

Proc Natl Acad Sci U S A. 1991; 88(6): 2384-7.

98. Ulutin ON, Ulutin SB, Ugur MS, Ulutin T, Erbengi T, Ferhanoglu B, T Y.

Defibrotide and its Effects on Platelet Function. In: Thrombosis and Haemorrhagic Disorders.

In: Vinazzer HSaH, ed. Schimmitt and Meyer GmBH Winzburg; 1989. p. 426-28.

99. Ulutin ON, Ulutin SB, Çizmeci G, T U, Ferhanoglu B. Some Clinical,

Pharmacological Observations of the Effect of Defibrotide in Human. Acta

Pharmaceutica Turcica. 1988; (30): 57-62.

Translation Editor of

1. Armitage JO, Atlas of Clinical Hematology, Lippncott Williams & Wilkins, ACT Medikal

İletişim, 2006. (Initial Press in 2004)

2. Kern W. F., PDQ Hematology, BC Decker Inc. , İstanbul Medikal Yayıncılık, 2005 (Initial

Press in 2002)

Book Sections

1. Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in

Turkish, Title: Diffuse Large B Cell Lymphoma). Ed. Teoman Soysal HematoLog-Special

Issue on Lymphoma. 2013; 3(2): 355-81.

2.Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article

published in Turkish, Title: Primary Central Nervous System Lymphomas). Ed. Teoman

Soysal HematoLog-Special Issue on Lymphoma. 2013; 3(2): 382-94.

3. Burhan Ferhanoğlu, “Anemia: Definition-Classification, Hematology Course Book”

(Anemiler: Tanım-Sınıflama, Hematoloji Ders Kitabı) Üniversite Yayın No: 4774,

Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 21-26, 2008.

4. Teoman Soysal, Burhan Ferhanoğlu, “Hematopoietic Stem Cell Transplantation,

Hematology Course Book” (Hematopoetik Kök Hücre Nakli, Hematoloji Ders Kitabı)

Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5,

sayfa: 207-217, 2008.

13

5. Burhan Ferhanoğlu, “Mechanism of Hemostasis, Hematology Course Book”

(Hemostaz Mekanizması, Hematoloji Ders Kitabı), Üniversite Yayın No: 4774, Cerrahpaşa

Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 219- 227, 2008.

6. Burhan Ferhanoğlu, “Trombphilia, Hematology Course Book” (Trombofili,

Hematoloji Ders Kitabı). Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269,

ISBN: 978-975-404-815-5, sayfa: 251-260, 2008.

7. Burhan Ferhanoğlu, “Anticoagulation Treatment, Hematology Course Book”

(Antikoagülan Tedavi, Hematoloji Ders Kitabı), Üniversite Yayın No: 4774, Cerrahpaşa

Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 261-264, 2008.

8. Burhan Ferhanoğlu, “Mechanism of Hemostasis, Tendency to Bleeding and

Thrombosis” (Hemostaz Mekanizması, Kanama ve Tromboza Eğilim), Editors: Burhan

Ferhanoğlu, Zafer Başlar, Tiraje Celkan, Cerrahpaşa Tıp Fak. Yayın No: 36, ISBN: 975-

8371-47-9, sayfa: 9-16, Kasım 2003.

9. Burhan Ferhanoğlu, “Trombophilia: Ways to Diagnosis, Tendency to Bleeding and

Thrombosis” (Trombofili: Tanıda İzlenecek Yol, Kanama ve Tromboza Eğilim), Editörler:

Burhan Ferhanoğlu, Zafer Başlar, Tiraje Celkan, Cerrahpaşa Tıp Fak. Yayın No: 36, ISBN:

975-8371-47-9, sayfa: 143-158, Kasım 2003.

Citations – Web of Science – Updated on 12nd of October, 2018

14

Awards

1. Burhan Ferhanoğlu, Ayşe Salihoğlu, Murat Özbalak, Teoman Soysal, İhsan Karadoğan,

Semra Paydaş, Evren Özdemir, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep

Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Özkocaman, Pervin Topçuoğlu,

Muhit Özcan, Elif Birtaş Ateşoğlu, Hakan Göker. “Long-term Results of Brentuximab

Vedotin in Relapsed/Refractory Hodgkin Lymphoma: Multi-center experience in

Turkey” (Nüks/Refrakter Hodgkin Lenfoma Vakalarında Brentuximab Vedotin’in

Uzun Dönem Sonuçları: Çok Merkezli Türkiye Deneyimi) Turkish Blood Network

Award (TÜRKBA Ödülü) in 43rd National Hematology Congress, Antalya, Turkey,

November 1-4, 2017

2. Ferhanoğlu B, Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T,

Sönmez M, Gülbaş Z, Özbalak M; “Nivolumab for Relapsed or Refractory Hodgkin

Lymphoma: Real-Life Experience” Best abstract award in “4th Aegean Hematology

Oncology Symposium”, Rhodes, Greece, September 21-24, 2017

3. Çetiner M, Sucak G, Aydın F, Birtaş E, Yozgatlıgil C, Kalaça S, Akı Z, Kalaycıoğlu-

Beşışık S, Ferhanoğlu B, Gülbaş Z, Uzay A, Kaygusuz I, Fıratlı- Tuğlular T, Bayık M;

“Evaluation of Life Quality in Hematopoietic Stem Cell Transplantation Patients”

(Hematopoyetik Kök Hücre Nakli Yapılan Hastalarda Yaşam Kalitesinin

Değerlendirilmesi) “Clinical Hematology” award in Turkish Society of Hematology 33rd

National Hematology Congress, Ankara, October 16-19, 2007.

4. Demirsoy ET, Ar MC, Öngören Ş, Üre Ü, Başlar Z, Ferhanoğlu B, Aydın Y, Tüzüner N,

Ülkü B, Aktuğlu G, Soysal T; “Prognostic Significance of Serum Vascular Endothelial

Growth Factor in Chronic Lymphocytic Leukemia” (Kronik Lenfositik Lösemide

Serum Vasküler Endotelyal Büyüme Faktörü Düzeyinin Prognoz Değeri) "Schering

Lymphoproliferative Disorders" second rank award in Turkish Society of Hematology

32nd National Hematology Congress, Antalya, 2006.

5. Özbalak M, Yürüyen M, Tüzüner N, Ar MC, Güner Şİ, Çetin G, Öngören Ş, Üre Ü, Başlar

Z, Soysal T, Aydın Y, Ülkü B, Demir G, Saçlı FS, Ferhanoğlu B; ““Response rates of

germinal center and non-germinal center subtypes of DLBCL to R-CHOP chemotherapy in

15

newly diagnosed diffuse large B cell lymphoma evaluated by immunohistochemistry” (Yeni

Tanı Almış Diffüz Büyük B Hücreli Lenfomada İmmünhistokimya Aracılığıyla

Değerlendirilen Doku Microarray Yöntemi ile Germinal Merkez ve Non-Germinal

Merkez Tiplerinin R-Chop Kemoterapisine Yanıtları) “Roche Non-Hodgkin

Lymphoma” award. (Turkish Society of Hematology Roche Industry Award) in Turkish

Society of Hematology 32nd National Hematology Congress, Antalya, 2006.

6. Ar MC, Sırma S, Hatırnaz Ö, Öngören Ş, Üre Ü, Başlar Z, Aydın Y, Ferhanoğlu B, Özbek

U; “Re-evaluation of Minimal Residual Disease by PCR IG/ TCR and Follow-up of

Minimal Residual Disease by Detection of Translocation in patients with Acute

Lymphoblastic Leukemia: Preliminary Results” (Erişkin Akut Lenfoblastik Lösemili

Hastalarda Minimal Rezidüel Hastalığın PCR IG/ TCR Yeniden Yapılanması ve

Translokasyon ile Tesbiti ve İzlenmesi: Ön Sonuçlar) “TSH Clinical Laboratory

Hematology” award in Turkish Society of Hematology 30th National Hematology Congress,

İstanbul, 2003

16